Genentech and JHL Biotech Settle Trade Secret Suit

Drug Industry Daily
A A
JHL Biotech has conceded to Genentech in a lawsuit over JHL’s development of biosimilars, to settle claims that it used stolen trade secrets to develop copycat drugs.

To View This Article:

Login

Subscribe To Drug Industry Daily